Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis
Authors
Keywords
-
Journal
Cell Communication and Signaling
Volume 18, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-01-24
DOI
10.1186/s12964-019-0505-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance
- (2019) Micol Eleonora Fiori et al. Molecular Cancer
- Sprouty2 loss‐induced IL6 drives castration‐resistant prostate cancer through scavenger receptor B1
- (2018) Rachana Patel et al. EMBO Molecular Medicine
- Feminization of Male Brown Treesnake Methyl Ketone Expression via Steroid Hormone Manipulation
- (2018) M. Rockwell Parker et al. JOURNAL OF CHEMICAL ECOLOGY
- Activation of hepatocyte growth factor/MET signaling initiates oncogenic transformation and enhances tumor aggressiveness in the murine prostate
- (2018) Jiaqi Mi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study
- (2017) Tomasz M. Beer et al. EUROPEAN UROLOGY
- Additive inhibitory effects of simvastatin and enzalutamide on androgen-sensitive LNCaP and VCaP prostate cancer cells
- (2016) Heimo Syvälä et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inhibition of AKR1C3 Activation Overcomes Resistance to Abiraterone in Advanced Prostate Cancer
- (2016) Chengfei Liu et al. MOLECULAR CANCER THERAPEUTICS
- Androgen deprivation therapy as backbone therapy in the management of prostate cancer
- (2016) Axel S Merseburger et al. OncoTargets and Therapy
- Critical role of androgen receptor level in prostate cancer cell resistance to new generation antiandrogen enzalutamide
- (2016) Julia Hoefer et al. Oncotarget
- Intracrine Androgens and AKR1C3 Activation Confer Resistance to Enzalutamide in Prostate Cancer
- (2015) C. Liu et al. CANCER RESEARCH
- Changes in Epithelium, Stroma, and Lumen Space Correlate More Strongly with Gleason Pattern and Are Stronger Predictors of Prostate ADC Changes than Cellularity Metrics
- (2015) Aritrick Chatterjee et al. RADIOLOGY
- Statin Use at the Time of Initiation of Androgen Deprivation Therapy and Time to Progression in Patients With Hormone-Sensitive Prostate Cancer
- (2015) Lauren C. Harshman et al. JAMA Oncology
- Cholesteryl Ester Accumulation Induced by PTEN Loss and PI3K/AKT Activation Underlies Human Prostate Cancer Aggressiveness
- (2014) Shuhua Yue et al. Cell Metabolism
- AKR1C3 overexpression may serve as a promising biomarker for prostate cancer progression
- (2014) Yuantong Tian et al. Diagnostic Pathology
- Emerging mechanisms of enzalutamide resistance in prostate cancer
- (2014) Frank Claessens et al. Nature Reviews Urology
- Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
- (2014) Tomasz M. Beer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Potential role of the OPG/RANK/RANKL axis in prostate cancer invasion and bone metastasis
- (2014) XIAOMING LI et al. ONCOLOGY REPORTS
- Development of a Multipurpose GATEWAY-Based Lentiviral Tetracycline-Regulated Conditional RNAi System (GLTR)
- (2014) Reinhard Sigl et al. PLoS One
- Quantitative Proteomics Reveals That Enzymes of the Ketogenic Pathway Are Associated with Prostate Cancer Progression
- (2013) Punit Saraon et al. MOLECULAR & CELLULAR PROTEOMICS
- Unknown
- (2013) Agus Hamid et al. MOLECULAR MEDICINE
- Dysregulation of Cholesterol Homeostasis in Human Prostate Cancer through Loss of ABCA1
- (2012) B. H. Lee et al. CANCER RESEARCH
- Distinct Patterns of Dysregulated Expression of Enzymes Involved in Androgen Synthesis and Metabolism in Metastatic Prostate Cancer Tumors
- (2012) N. Mitsiades et al. CANCER RESEARCH
- Overexpression of aldo-keto reductase 1C3 (AKR1C3) in LNCaP cells diverts androgen metabolism towards testosterone resulting in resistance to the 5α-reductase inhibitor finasteride
- (2012) Michael C. Byrns et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
- (2011) Charles E Massie et al. EMBO JOURNAL
- Human HMGCS2 Regulates Mitochondrial Fatty Acid Oxidation andFGF21Expression in HepG2 Cell Line
- (2011) Anna Vilà-Brau et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lovastatin Causes Diminished PSA Secretion by Inhibiting AR Expression and Function in LNCaP Prostate Cancer Cells
- (2011) Lin Yang et al. UROLOGY
- Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study
- (2010) Howard I Scher et al. LANCET
- Men with Low Serum Cholesterol Have a Lower Risk of High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial
- (2009) E. A. Platz et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Squalene synthase: a critical enzyme in the cholesterol biosynthesis pathway
- (2009) R Do et al. CLINICAL GENETICS
- Enhanced antiproliferative and proapoptotic effects on prostate cancer cells by simultaneously inhibiting androgen receptor and cAMP-dependent protein kinase A
- (2009) Andreas Desiniotis et al. INTERNATIONAL JOURNAL OF CANCER
- Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
- (2009) C. Tran et al. SCIENCE
- The Influence of Statin Medications on Prostate-specific Antigen Levels
- (2008) Robert J. Hamilton et al. JNCI-Journal of the National Cancer Institute
- Ketone bodies as a therapeutic for Alzheimer’s disease
- (2008) Samuel T. Henderson Neurotherapeutics
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search